Your browser doesn't support javascript.
Evaluation of stability and inactivation methods of SARS-CoV-2 in context of laboratory settings.
Widera, Marek; Westhaus, Sandra; Rabenau, Holger F; Hoehl, Sebastian; Bojkova, Denisa; Cinatl, Jindrich; Ciesek, Sandra.
  • Widera M; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany. marek.widera@kgu.de.
  • Westhaus S; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
  • Rabenau HF; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
  • Hoehl S; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
  • Bojkova D; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
  • Cinatl J; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
  • Ciesek S; Institute for Medical Virology, University Hospital Frankfurt am Main, Goethe University, Paul-Ehrlich-Str.40, 60596, Frankfurt am Main, Germany.
Med Microbiol Immunol ; 210(4): 235-244, 2021 Aug.
Article in English | MEDLINE | ID: covidwho-1292088
Preprint
This scientific journal article is probably based on a previously available preprint. It has been identified through a machine matching algorithm, human confirmation is still pending.
See preprint
ABSTRACT
The novel coronavirus SARS-CoV-2 is the causative agent of the acute respiratory disease COVID-19, which has become a global concern due to its rapid spread. Laboratory work with SARS-CoV-2 in a laboratory setting was rated to biosafety level 3 (BSL-3) biocontainment level. However, certain research applications in particular in molecular biology require incomplete denaturation of the proteins, which might cause safety issues handling contaminated samples. In this study, we evaluated lysis buffers that are commonly used in molecular biological laboratories for their ability to inactivate SARS-CoV-2. In addition, viral stability in cell culture media at 4 °C and on display glass and plastic surfaces used in laboratory environment was analyzed. Furthermore, we evaluated chemical and non-chemical inactivation methods including heat inactivation, UV-C light, addition of ethanol, acetone-methanol, and PFA, which might be used as a subsequent inactivation step in the case of insufficient inactivation. We infected susceptible Caco-2 and Vero cells with pre-treated SARS-CoV-2 and determined the tissue culture infection dose 50 (TCID50) using crystal violet staining and microscopy. In addition, lysates of infected cells and virus containing supernatant were subjected to RT-qPCR analysis. We have found that guanidine thiocyanate and most of the tested detergent containing lysis buffers were effective in inactivation of SARS-CoV-2, however, the M-PER lysis buffer containing a proprietary detergent failed to inactivate the virus. In conclusion, careful evaluation of the used inactivation methods is required especially for non-denaturing buffers. Additional inactivation steps might be necessary before removal of lysed viral samples from BSL-3.
Subject(s)
Keywords

Full text: Available Collection: International databases Database: MEDLINE Main subject: Thiocyanates / Virus Inactivation / SARS-CoV-2 / COVID-19 / Guanidines / Anti-Infective Agents Type of study: Experimental Studies / Observational study Limits: Animals / Humans Language: English Journal: Med Microbiol Immunol Year: 2021 Document Type: Article Affiliation country: S00430-021-00716-3

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Main subject: Thiocyanates / Virus Inactivation / SARS-CoV-2 / COVID-19 / Guanidines / Anti-Infective Agents Type of study: Experimental Studies / Observational study Limits: Animals / Humans Language: English Journal: Med Microbiol Immunol Year: 2021 Document Type: Article Affiliation country: S00430-021-00716-3